A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF THE THERION RECOMBINANT VACCINIA-HIV-1 IIIB ENV/GAG/POL VACCINE (TCB-3B) AND MN RGP 120/HIV-1 IN ALUM.: